{"id":5148,"date":"2022-09-06T15:52:41","date_gmt":"2022-09-06T13:52:41","guid":{"rendered":"https:\/\/www.hartwigmedicalfoundation.nl\/?post_type=datarequests&#038;p=5148"},"modified":"2022-09-06T15:52:41","modified_gmt":"2022-09-06T13:52:41","slug":"dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors","status":"publish","type":"datarequests","link":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/datarequests\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\/","title":{"rendered":"DR-299 MutSig &#8211; The incidence and co-ocurrence of genomic biomarkers in metastatic tumors"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The observed incidence of cancer biomarkers can influence resource investment into key areas such as drug discovery and companion diagnostic technology. The list of clinically relevant cancer biomarkers is growing, however a systematic description of the incidence of these biomarkers is currently lacking. Understanding the prevalence of these biomarkers in late-stage cancer can be especially relevant since many companion diagnostics are utilized in the treatment of stage III and IV cancers.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">By using multiple publicly available knowledge management resources that describe clinically relevant alterations, we aim to characterize the frequency of these biomarkers and contextualize their associations within the Hartwig dataset.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Eivind Hovig, \u00a0University of Oslo, Norge<\/p>\n","protected":false},"author":3,"featured_media":0,"template":"","request_years":[99],"class_list":["post-5148","datarequests","type-datarequests","status-publish","hentry","request_years-99"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>DR-299 MutSig - The incidence and co-ocurrence of genomic biomarkers in metastatic tumors - Hartwig Medical Foundation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hartwigmedicalfoundation.nl\/en\/datarequests\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DR-299 MutSig - The incidence and co-ocurrence of genomic biomarkers in metastatic tumors - Hartwig Medical Foundation\" \/>\n<meta property=\"og:description\" content=\"The observed incidence of cancer biomarkers can influence resource investment into key areas such as drug discovery and companion diagnostic &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hartwigmedicalfoundation.nl\/en\/datarequests\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\/\" \/>\n<meta property=\"og:site_name\" content=\"Hartwig Medical Foundation\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/datarequests\\\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\\\/\",\"url\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/datarequests\\\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\\\/\",\"name\":\"DR-299 MutSig - The incidence and co-ocurrence of genomic biomarkers in metastatic tumors - Hartwig Medical Foundation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#website\"},\"datePublished\":\"2022-09-06T13:52:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/datarequests\\\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/datarequests\\\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/datarequests\\\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Data Requests\",\"item\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/datarequests\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DR-299 MutSig &#8211; The incidence and co-ocurrence of genomic biomarkers in metastatic tumors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#website\",\"url\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/\",\"name\":\"Hartwig Medical Foundation\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DR-299 MutSig - The incidence and co-ocurrence of genomic biomarkers in metastatic tumors - Hartwig Medical Foundation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/datarequests\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\/","og_locale":"en_US","og_type":"article","og_title":"DR-299 MutSig - The incidence and co-ocurrence of genomic biomarkers in metastatic tumors - Hartwig Medical Foundation","og_description":"The observed incidence of cancer biomarkers can influence resource investment into key areas such as drug discovery and companion diagnostic &hellip;","og_url":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/datarequests\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\/","og_site_name":"Hartwig Medical Foundation","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/datarequests\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\/","url":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/datarequests\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\/","name":"DR-299 MutSig - The incidence and co-ocurrence of genomic biomarkers in metastatic tumors - Hartwig Medical Foundation","isPartOf":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#website"},"datePublished":"2022-09-06T13:52:41+00:00","breadcrumb":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/datarequests\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hartwigmedicalfoundation.nl\/en\/datarequests\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/datarequests\/dr-299-mutsig-the-incidence-and-co-ocurrence-of-genomic-biomarkers-in-metastatic-tumors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Data Requests","item":"https:\/\/www.hartwigmedicalfoundation.nl\/datarequests\/"},{"@type":"ListItem","position":2,"name":"DR-299 MutSig &#8211; The incidence and co-ocurrence of genomic biomarkers in metastatic tumors"}]},{"@type":"WebSite","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#website","url":"https:\/\/www.hartwigmedicalfoundation.nl\/","name":"Hartwig Medical Foundation","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hartwigmedicalfoundation.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/datarequests\/5148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/datarequests"}],"about":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/types\/datarequests"}],"author":[{"embeddable":true,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/users\/3"}],"wp:attachment":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/media?parent=5148"}],"wp:term":[{"taxonomy":"request_years","embeddable":true,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/request_years?post=5148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}